Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (591-600 of 645) with videos related to

Pageof 65
Sort By:
Critical Care Medicine|October 1, 2019
One-Year Prognosis of Kidney Injury at Discharge From the ICU: A Multicenter Observational StudyMatthieu Legrand, Alexa Hollinger, Antoine Vieillard-Baron, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
Critical Care (London, England)|January 20, 2018
Determinants of long-term outcome in ICU survivors: results from the FROG-ICU studyEtienne Gayat, Alain Cariou, Nicolas Deye, et al.
Pageof 65

Showing results (591-600 of 645) with videos related to

Sort By:
Pageof 65
Critical Care Medicine|October 1, 2019
One-Year Prognosis of Kidney Injury at Discharge From the ICU: A Multicenter Observational StudyMatthieu Legrand, Alexa Hollinger, Antoine Vieillard-Baron, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
Critical Care (London, England)|January 20, 2018
Determinants of long-term outcome in ICU survivors: results from the FROG-ICU studyEtienne Gayat, Alain Cariou, Nicolas Deye, et al.
Pageof 65